Purpose: Given the burgeoning body of research relating to the psychosocial needs of adolescents and young adults (AYAs) with cancer, this review aimed to evaluate the psychometric properties and appropriateness of the instruments available for use in this unique population. Specifically, we reviewed published instruments developed to assess psychological distress (depression, anxiety, stress, and fear of recurrence), psychological growth (resilience, posttraumatic growth, and benefit finding), unmet needs, coping, quality of life, identity, and mindfulness-based practices and skills in AYAs with cancer. Given the dearth of validated instruments targeting AYAs with cancer, this review also provides a summary of promising measures yet to be formally validated in this population. Methods: Five electronic databases were searched by a team of six researchers, and studies involving AYAs (who have or have had cancer) aged 15-30 years, and published between 1982 and 2012 were reviewed. Of 410 abstracts, 7 instruments were identified as validated in this population, with a further 19 identified as promising. Results: While there are numerous scales to assess psychosocial outcomes in cancer, few have been specifically validated for AYAs affected by cancer, particularly in the domains of psychological distress, psychological growth, coping, unmet needs, and identity. There are relatively more instruments validated, or promising, for assessment of quality of life than scales for other domains. Conclusion: In the AYA context, scale selection should be undertaken with thought directed towards the characteristics of this sample (eg, developmental maturity, literacy, and social context), the practicalities of the setting (eg, available funding and resources, time restrictions, and researcher expertise), and the science underlying the scale (eg, theoretical framework and psychometric properties). While multiple measures of psychosocial outcomes are frequently used in AYAs, further research is clearly needed to provide rigorous evidence of the reliability and validity of these tools in young people affected by cancer.
Introduction
Increasing research interest in the unique experience of cancer in adolescence and young adulthood has resulted in a burgeoning number of studies investigating psychosocial outcomes in this population. 1 To date, many of these studies have been descriptive; documenting the prevalence of negative constructs, such as psychological distress. 2 Others have begun to examine more positive outcomes, such as hopefulness and resilience, 3 or to investigate the co-occurrence of both negative and positive outcomes within the same study. 4, 5 Interest in the measurement of unmet needs has similarly increased over the past 10 to 20 years. 6 Evidence indicates that adolescents and young adults (AYAs) affected by, or recovering from, cancer are at increased risk of poorer psychological functioning compared to their peers, 2 or to children and/or adults with cancer. 2 Consequently, many researchers have turned their attention to developing and evaluating the impact of interventions designed to improve psychosocial outcomes in this population. [7] [8] [9] In this context, the availability of ageappropriate, validated tools to assess psychosocial outcomes is paramount.
AYAs affected by cancer are developmentally unique, meaning that their needs and experiences may not be fully captured by existing instruments developed for children or adults. 10 Compared to children with cancer, AYAs with cancer may be less likely to comply with their treatment regimen 11 and are more likely to engage in risky activities during or after their treatment (eg, smoking, unsafe sex). 4, 12 These factors may affect how AYAs transition into well-functioning survivorship. Compared to adults with cancer, AYAs may be less health literate, 13 have a reduced ability to understand health risks associated with their condition, 12 and place a relatively higher importance on their peer relationships. 14 AYAs affected by cancer are also likely to use the Internet and social media more often than children and adults, 15 are less likely to have adequate insurance, 16 and are less likely to seek medical attention when confronted with concerning medical symptoms. 17, 18 These issues span across cancer types, age, gender, and cultural groups, and may affect not only the AYA, but also his or her entire family. 19 Such age-specific individual and social factors are highly likely to shape both the nature and severity of the distress that AYAs with cancer experience. Consequently, existing measures validated for younger children or adults may not be appropriate for the AYA age group.
Conducting research on young people with cancer has specific challenges. These include, but are not limited to: AYAs being less likely to participate in clinical 20, 21 and psychosocial research, 22 and being less likely to be treated by physicians affiliated with research institutions than other populations. 16 They are also likely to be spread across both pediatric and adult health care institutions, yet make up a small proportion of the caseload for either type of health care service. 16, 23 They may use different language or jargon than children and adults with cancer, and may find it difficult to communicate with their physician about sensitive issues. 24 Therefore, as the landscape of AYA research expands, so does the complexity of selecting appropriate measures to assess psychosocial outcomes in this population.
When making decisions about which instruments to use in AYA psychosocial outcomes research, it is important that researchers consider both the potential clinical utility (and appropriateness) of a scale, and its psychometric properties. Relative to the proportion of studies measuring psychosocial outcomes, little research to date has focused on the tools used to perform these measurements. In particular, there is a lack of research identifying and evaluating age-appropriate instruments that are relevant and appealing to young people, comparable across studies, and sensitive to change as AYAs with cancer progress through treatment into survivorship or palliative care.
In this study, therefore, we aimed to review the psychometric properties and appropriateness of the instruments available for use in psychosocial research in AYAs who have, or have had, cancer. Specifically, we reviewed published instruments developed to assess psychological distress (depression, anxiety, stress, and fear of recurrence), psychological growth (resilience, posttraumatic growth, and benefit finding), unmet needs (including readiness for transition to adult health services), coping, quality of life (QOL), and identity in AYAs with cancer. In recognition of the increasing interest in mindfulness-based work with young people, 25 we also searched for scales assessing mindfulness-based practices and skills in AYAs, such as psychological flexibility, defusion, and expansion. Given the dearth of scales validated for AYAs with cancer, the review also provides a summary of promising instruments that have been used in or developed for AYAs with cancer, but are yet to be formally validated. The key research questions considered were: 1. What validated instruments are available to measure psychosocial outcomes in AYAs who have, or have had, cancer, and what are their psychometric properties? 2. What other promising instruments have been used in or developed for AYAs who have, or have had, cancer that are yet to be formally validated for this population? 3. What are the gaps, if any, in terms of rigorously assessing psychosocial outcomes in young people with cancer?
Methods
The review was conducted according to gold-standard systematic review procedures. 26 This involved determining, a priori, a set of inclusion and exclusion criteria; conducting a rigorous literature search across five databases using a standardized abstract screening and study selection process; clearly documenting excluded studies; and using consistent data extraction methods.
Search strategy
Five electronic databases were searched; MEDLINE, MED-LINE In Process and Non-Indexed Citations, PsycINFO, EMBASE, and SWABS, and were limited to human studies published in the English language between January 1982 and August 2012. In each database, searches for terms defining the age group, the disease, the study type, the methodology adopted, and the outcomes of interest were run and combined. 
inclusion criteria
Studies published in peer-reviewed journals that validated a measure of one of this study's domains of interest for AYAs were included in this review. Domains reviewed included psychological distress (depression, anxiety, stress, and fear of recurrence), psychological growth (resilience, posttraumatic growth, and benefit finding), unmet needs (including readiness for transition to adult health services), coping (control and efficacy), QOL, identity, and mindfulness-based practices and skills (psychological flexibility, defusion, and expansion) in AYAs with cancer. Excluded from the review were instruments assessing other health-related beliefs (eg, body image, sexuality, spirituality, and fertility concerns), health-related behaviors (eg, sun protection practices, smoking behavior, and physical activity), family functioning (including relationships with parents and siblings), and satisfaction with health care and services. Scales solely assessing symptom-related aspects, such as fatigue, nausea, or pain, were not included, except in cases where these symptom-related aspects formed part of a global assessment of QOL.
In order to capture all possibly relevant instruments in the cancer context and to increase consistency across the field, instruments were included when validated with participants in the same age range, as defined by Clinton-McHarg and colleagues. 27 The target age range was, therefore, exactly 15-30 years; however, scales developed for individuals younger than 15 years (with an upper age limit of 15-30 years), and scales developed for individuals older than 15 years (but with an upper age limit of 30 years) were also included. Where studies included participants outside this age range (eg, the study only included adults aged 18+), instruments were still included if the study reported subgroup data on any participants within the target age range (eg, if an "adult" study reported data for individuals 18-30 years old separately from the whole dataset).
The age range criteria specifically targeted studies with participants who were currently in the 15-30 age range, regardless of their age at diagnosis of cancer. This approach was adopted in order to identify measurement scales appropriate for patients and other individuals who were currently experiencing the AYA developmental stage. Thus, studies that included survivors of pediatric cancer who were aged 15-30 years were included, while studies assessing outcomes in survivors of adolescent cancer who were older than 30 years when they participated in the research were excluded. Studies were included if participants were receiving active treatment for their illness, were in remission, or had been cured of their condition (ie, were in survivorship). Only the most recent published report of any given instrument was included.
Study selection
After deduplicating, the resulting 410 abstracts were screened by six researchers in two screening teams (PP, FM, ED and CW, USD, HW) using the inclusion criteria listed above. Inter-rater reliability was 98% (eight disagreements out of 410 abstracts). Full-text articles were extracted for all abstracts that either appeared eligible to at least one reviewer, or which did not yield sufficient information for review, to confirm eligibility. Consensus between the researchers in each team was achieved by discussing and clarifying details against the full-text article. Studies not fitting the inclusion criteria were discarded, with the primary reasons for exclusion being: (1) lack of data specific to the targeted age range; (2) focus on another domain, such as attitudes toward smoking or safe sexual practices; (3) a medical trial that did not address psychosocial domains; (4) a different primary disease, such as diabetes or HIV; and (5) the instrument was not available in English.
To augment the electronic search, reference lists of included studies and tables of contents of key journals were examined manually to identify additional relevant studies. This led to the inclusion of a further nine articles.
Assessment of selected instruments
The team used well-established guidelines [28] [29] [30] and the criteria described in Clinton-McHarg et al 27 to evaluate the performance of each instrument. Briefly, each instrument was assessed for seven domains using the following criteria: 1. Internal reliability -acceptable if the reported Cronbach's alpha coefficient was 0.70 or greater. 31 2. Test-retest reliability -acceptable if the correlations between the measure administered at two time points were .0.7 (Pearson or intraclass correlation coefficient) or .0.6 (Cohen's kappa co-efficient). 3. Content validity -acceptable if the scale had been evaluated logically by a consensus of expert opinions.
Convergent and discriminative validity -acceptable
if correlations between similar conceptual constructs were .0.4, and/or correlations between conceptually dissimilar constructs were ,0.3. Alternatively, if factor analysis was conducted, the measure was acceptable if eigenvalues of .1 were achieved for each factor. 5. Responsiveness -acceptable if less than 5% of participants received the highest and lowest scores (ie, floor and/or ceiling effects were minimal) or if the scale was able to detect a change with an effect size of .0.5. 6. Acceptability -assessed according to participant burden (ie, number of items and time to complete) and missing items.
Results
The review identified a total of seven validated instruments assessing psychosocial outcomes in AYAs with cancer (see Tables 1, 3 and 4) , and highlighted a further 19 promising scales (see Table 2 ). The findings from each domain are summarized below.
Measures of psychological distress
The review identified only one measure, the Uncertainty Scale for Kids, 32 in the area of depression, anxiety, and stress, and this was available in English only. No specific measures for assessing fear of cancer recurrence were identified. A number of other measures were identified as promising, namely the Distress Thermometer and the modified Problem List for Adolescents and Young Adults; 33, 34 the Distress Rating Scale (modified version of the Distress Thermometer); 35 the Beck Youth Inventory-II (BYI-II); 36 and the Brief Symptom Inventory-18 (BSI-18). 36 However, the anxiety and depression BYI-II scales are rather lengthy (20 items each) and while the BSI-18 is considerably shorter, it has been developed for individuals 18 years and older. Taking into account that none of these measures have been formally validated in AYAs who have, or have had, cancer, the Distress Thermometer currently appears to be both an accessible and brief option to measure psychological distress in this population.
Measures of psychological growth
The review identified two measures of psychological growth validated for AYAs with cancer; namely, the Perceived Benefits Scale 37 and the Herth Hope Index. 38 Both scales appear to have acceptable internal consistency, are reasonably brief and are available in additional languages (although they have not necessarily been validated for AYAs in these languages). However, neither scale has been assessed for test-retest reliability and are yet to be used in large samples of young people affected by cancer.
One scale was identified as promising -the Benefit/ Burden scale for Children; 39 however, to date, this has primarily been used for children and younger adolescents with cancer. Other well-known scales, such as the Child and Youth Resilience measure (CYRM-28), 40 the Child Health and Illness Profile-Adolescent Edition (CHIP-AE), 41 and the Strengths and Difficulties Questionnaire, 42 are yet to be validated in AYAs who have, or have had, cancer. Despite strong research interest in posttraumatic growth in cancer, 43 there was a clear gap in validated scales assessing posttraumatic growth in AYAs with cancer, or in survivors.
Measures of unmet needs
The review identified one measure of unmet needs developed for, and validated among, the AYA population: the Cancer Needs Questionnaire for Young People (CNQ-YP). 44 While the CNQ-YP has been validated, it is a relatively new measure and has not been validated in populations outside Australia. Additionally, many of the unmet needs measures developed for the adult population are for specific themes or sub-groups and, hence, can be shorter. No specific instruments addressing transitioning from the pediatric to the adult hospital system met the criteria for promising or validated. Several instruments were found assessing unmet needs in other population groups, in particular with specific adult cancer groups; [45] [46] [47] however, none of these had been developed for the AYA population nor had specific data regarding young people affected by cancer. One paper, which investigated satisfaction with information and services provided (which was somewhat related to unmet needs), examined the impact of age and found some differences in their youngest age group of 18-39 year olds, highlighting the need to validate such instruments in the AYA age range. 
English Chinese
Herth Hope index 38
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A self-report assessment to measure global, non time-oriented hope. Three subscales: temporality and future (eg, perception that a positive outcome is probable in the near future); readiness and expectancy (eg, feeling of confidence with initiation of plans to affect desired outcome); and interconnectedness (eg, recognition of the interdependence and interconnectedness between self and others and between self and spirit). items use a Likert scale from 1 (strongly disagree) to 4 (strongly agree). Maximum score = 48, where a higher score indicates higher hopefulness. A self-report measure of coping strategies in children with cancer. Three domains: cognitive coping (14), problem-oriented coping (9), defensive coping (10).
Chinese. Available in English,
but not yet validated in AYAs with cancer in this language. 
Quality of life measures
Measures of coping
One measure of coping validated in the target population was identified, namely, the Pediatric Cancer Coping Scale, which was specifically validated in a Taiwanese AYA population. 49 While the scale performed well in Taiwanese young people, the English version does not yet appear to have been formally validated in AYAs. Several instruments were identified as promising coping measures. These include the 14-item Treatment-related Coping and Compliance Scale, 6 and the Mental Adjustment to Cancer Scale, which has been used extensively in cancer, and was administered to cancer patients as young as 16 years old in one study. 50 The Kid-Cope 51 has been used in young people with cancer in several studies, 8, 52 and is designed to assess cognitive and behavioral coping strategies. The Coping Strategies Inventory 53 also showed promise, assessing coping thoughts and behaviors in response to a specific stressful experience.
Measures of QOL
Of the QOL scales identified, each varied in length (ranging from 14-82 items) and domains measured (five to ten domains per scale). Despite the number of QOL scales available, only two have been validated across the entire age range of AYAs. These include the AYA modified Pediatric Quality of Life Inventory Generic Core Scales (23 items) and Cancer Module (27 items) (PedsQL-AYA 54 ) and the 41-item Quality of Life-Cancer Survivors scale (QOL-CS). 55 Both of these scales reported excellent internal consistency, good convergent/discriminant validity, and were able to significantly discriminate between known groups (eg, by symptom severity). These two scales, however, differ in their focus; the QOL-CS is targeted toward childhood cancer survivors, while the PedsQL-AYA incorporates aspects that would be relevant to on-or recently off-treatment AYA cancer patients (eg, nausea and treatment anxiety). Only the PedsQL-AYA reported conducting focus groups with AYA patients, family members, and health or allied health professionals to ensure content validity. Neither scale reported test-retest reliability.
Numerous QOL measures also show promise in the AYA age group. These scales ranged from the very brief Adolescent Quality of Life scale (AQOL, 16 items), 56, 57 to the extensive Impact of Cancer Scale-Childhood Cancer Survivors (IOCS-CS, 82 items), 58, 59 measured between five to ten domains, and have been validated with young people -both those undergoing, and who have finished, cancer treatment. Most of the promising QOL measures were validated for the younger part of the age group (ie, younger adolescents, as young as 8 years old). These included the AQOL, 56, 57 the Minneapolis-Manchester Quality of Life Instrument-Adolescent form (MMQL-Adolescent), 60 the Pediatric Quality of Life Inventory-Adolescent form (PedsQL-Adolescent), 61 which formed the basis of the PedsQL-AYA scale, 54 the Pediatric Cancer Quality of Life Inventory-32-item short form 62 and Modular Approach, 63 and two versions of the Perceived Illness Experience Scale. 64, 65 Two scales have been developed for older AYAs: the IOCS-CS, 58, 59 and the Late Adolescent and Young Adult -Survivorship-Related Quality of Life measure (LAYA-SRQL). 66, 67 All promising measures appeared to have acceptable internal consistency, and several were able to significantly detect differences between young people according to treatment stage (AQOL, MMQL-Adolescent, PCQL-32, PCQL-Modular, and PIE). However, few of these scales reported test-retest reliability or sensitivity to change over time.
Measures of identity
The review did not identify any scales to assess the construct of identity, nor were there any suitable for the promising classification. This finding represents a clear gap given both the importance of this construct for the AYA population and the potential impact of a life-threatening disease, such as cancer, on identity development. 14, 68 
Measures of mindfulness-based practice and skills
As with the domain of identity, no validated mindfulnessbased measures were identified from the review and there were none that fit the promising classification. Given the growing body of literature attesting to the benefits of mindfulness-based practices and skills within the cancer population, [69] [70] [71] including AYAs, 25 it would seem pertinent to have access to scales validated with AYAs with cancer measuring this construct.
Discussion
The ways in which clinicians, psychologists and researchers think about and define outcomes in young people are varied. The present paper evolved out of our own and our colleagues' recognition of the difficulties encountered when selecting the most suitable or appropriate outcome measures for conducting research in this age group. The review highlights the dearth of instruments available to assess psychosocial outcomes in young people affected by cancer, and reveals an interesting imbalance of available instruments across domains. While some domains are understandably under-represented, given their relatively submit your manuscript | www.dovepress.com
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Convergent/divergent validity Responsiveness Acceptability
Anxiety (r = 0.56, P = 0.001) Depressive symptoms (r = 0.59, P , 0.001) Cancer knowledge (r = -0.27, P = 0.02) issue of transitioning from pediatric to adult care, despite clinical and research acknowledgement that transition is a key time of need for young people with cancer. 75, 76 In contrast, the development of QOL measures for AYAs with, or recovering from, cancer is more advanced (particularly for younger adolescents). While many of these scales incorporate assessment of young peoples' emotional wellbeing and/or functioning, QOL measures are a more distal measure of distress than instruments targeting specific psychological domains. This is interesting, given that many interventions have been developed to target specific psychological domains (eg, depression, anxiety, and posttraumatic stress), yet many use QOL as their primary outcome measure given the lack of other validated alternatives. QOL instruments typically comprise a mixture of variables that may cause poor QOL ("causal variables," eg, nausea) and variables that may be reflective of poor QOL in general ("indicator variables," eg, distress), 77 and so it is possible that psychosocial interventions may be able to change the indicator variables (eg, reduce distress) but not the causal variables, as these variables are more difficult to change and do not necessarily belong to the same latent construct (eg, nausea, communication issues, and financial concerns). 77 Consequently, global QOL assessment comprising a mix of related factors may form a less sensitive measure of distress or emotional wellbeing than other more specific constructs.
In addition, neither of the two QOL scales validated across the AYA age range (PedsQL-AYA and the QOL-CS), appear to comprehensively assess AYA-specific issues, such as drug/alcohol consumption, fertility, sexuality/intimacy, or dating concerns (although there are some scales specifically assessing these aspects of the young person's experience not captured here). By contrast, the two promising QOL scales identified for older AYAs (IOCS-CS and LAYA-SRQL), do include aspects that may be important for the whole AYA age range (eg, body image, financial issues, career, and sexuality and fertility concerns). These content aspects may make these scales uniquely applicable to the developmental concerns of AYAs, unlike many of the instruments developed for younger adolescents.
implications for future instrument development
Finding instruments tested across the entire AYA age range is challenging. Both pediatric and adult cancer fields, therefore, need to be aware of the unique psychosocial issues of AYAs and consider the needs of this population when developing pediatric and adult instruments. One solution may be for the age groups of potentially useful scales to be extended (upwards or downwards) to capture an age span between 15 and 25 years. Even without extending the age ranges tested for existing instruments, presenting validation data for subgroups of AYAs separately would be beneficial in order to assess whether a general scale is valid and reliable in this specific age range (eg, presenting subgroup data for [15] [16] [17] [18] year olds completing children's scales, or for 18-25 year olds completing adult scales, separately). This would ensure that scales covering more domains could be used in AYAs and may also contribute to reducing the "gap" between AYA and adult outcomes 23, 78 by ensuring that their psychosocial functioning can be reliably and validly assessed.
There is also clear need for instruments already commonly used in young people with cancer (despite not having been validated in this population) to be tested to ensure the unique needs of young people are captured by these instruments (eg, the Distress Thermometer and modified Problem List for Adolescents and Young Adults; 34 Hospital Anxiety and Depression Scale; 79 the Depression, Anxiety and Stress Scale; 80 and the K-10 81 ). Across the pool of scales identified in all psychosocial domains, there was also a lack of consistent reporting of important validity data such as test-retest reliability, responsiveness/sensitivity to change over time, and acceptability/relevance of the final scale to consumers representing different groups (eg, young people who are on versus off cancer treatment).
Consideration should also be given to validating existing measures specifically developed for young people with the AYA cancer population. For example, mindfulness-based practice and skills is an area of increasing interest and existing measures, such as the Child and Adolescent Mindfulness Measure (CAMM) 82 and the Avoidance and Fusion Questionnaire for Youth (AFQ-Y), 83 could be very useful in measuring these important constructs in young people who have, or have had, cancer.
Finally, tools specifically developed to assess the unique experience of coping with cancer, psychological growth (eg, resilience), and identity in AYAs with cancer are also urgently needed. So too are instruments developed for specific needs groups, including AYAs with culturally and linguistically diverse backgrounds (recognized as a critical variable in families of children with cancer, 84 adults with cancer, 85, 86 and in adolescents with chronic illness 87 ), as well as other minority groups (eg, individuals with same-sex attraction 88 ). implications for future instrument selection It is unclear how often researchers are using the "best available" instrument to assess the impact of cancer and/or its treatment on young people. Researchers may also not be using valid and reliable instruments when assessing the efficacy of psychosocial or other interventions developed for this age group. Future instrument selection, therefore, must be undertaken with care and thought directed toward the characteristics of the AYA sample (eg, literacy, culture, medical condition), the practicalities of the setting (eg, available funding and resources, time restrictions, and researcher expertise), the specific aspect of the cancer experience to be studied, and the science underlying the scale (eg, theoretical framework and psychometric properties). Administratively, research instruments need to be easy for clinic staff to distribute, and should aim to minimize the burden on young respondents.
Conclusion
The goal of this review was to provide clinicians and researchers with concise and workable descriptions of all the published instruments assessing psychosocial functioning in the AYA oncology setting. Recent research has contributed a great deal to our understanding of AYAs' experiences when being treated for, 5 or recovering from, 89 cancer. However, a broader investigation of the complexities of AYA outcomes and their measurement is clearly warranted. These findings have important implications for how future interventions for this population will be developed and evaluated. The limited number of available tools in psychosocial domains (other than QOL) may be seriously restricting researchers' abilities to validly and sensitively measure impact, or change, in psychosocial functioning in an important cohort of individuals affected by cancer.
